SCHEMBL5164514

SCHEMBL5164514

Nc1ccc(O)cc1CC(=O)NCCO

nearest known ligand 0.39

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
CNR2 P34972 4/20 0.39
CNR1 P21554 3/20 0.39
PCNA P12004 1/20 0.39
MEN1 O00255 1/20 0.36
KMT2A Q03164 1/20 0.36
CDK5 Q00535 1/20 0.36
CDK5R1 Q15078 1/20 0.36
EGFR P00533 2/20 0.35
GAA P10253 1/20 0.35
KDM4E B2RXH2 1/20 0.35
ALDH1A1 P00352 1/20 0.35
MAPT P10636 1/20 0.35
CASP1 P29466 1/20 0.35
CASP7 P55210 1/20 0.35
TRPV1 Q8NER1 1/20 0.35
ESRRB O95718 1/20 0.35
ESRRG P62508 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5163737 0.91 PTGS2 (0.42) CNR2CNR1MEN1KMT2ACDK5
SCHEMBL5160286 0.88 PDK2 (0.38) MEN1KMT2ACDK5CDK5R1EGFR
SCHEMBL5161617 0.86 TSHR (0.41) KMT2AEGFRGAAKDM4EALDH1A1
SCHEMBL5163009 0.84 CA1 (0.49) MEN1KMT2AEGFRKDM4EMAPT
SCHEMBL5162190 0.83 MEN1 (0.40) MEN1KMT2AEGFR
SCHEMBL5159732 0.82 CA2 (0.50) EGFRKDM4E
Ammonia Solution, Strong SCHEMBL5159727 0.81 CA2 (0.49) EGFRKDM4E
SCHEMBL1161708 0.81 MEN1 (0.50) CNR2CNR1MEN1KMT2A
SCHEMBL5159800 0.80 ALDH1A1 (0.47) MEN1KMT2AGAAKDM4EALDH1A1
SCHEMBL5164205 0.80 MEN1 (0.36) MEN1KMT2AEGFRGAAKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070067922-A1 4-Aminophenol derivatives and colorants comprising these compounds PROCTER & GAMBLE COMPANY, THE 2007-03-29 US claimed
EP-1762218-A1 4-aminophenol derivatives and colorants comprising these compounds Wella Aktiengesellschaft (DE) 2007-03-14 EP claimed
WO-2007026313-A2 4-AMINOPHENOL DERIVATIVES AND COLORANTS COMPRISING THESE COMPOUNDS THE PROCTER & GAMBLE COMPANY (US) 2007-03-08 WO claimed
US-20070067922-A1 4-Aminophenol derivatives and colorants comprising these compounds PROCTER & GAMBLE COMPANY, THE 2007-03-29 US disclosed
EP-1762218-A1 4-aminophenol derivatives and colorants comprising these compounds Wella Aktiengesellschaft (DE) 2007-03-14 EP disclosed
WO-2007026313-A2 4-AMINOPHENOL DERIVATIVES AND COLORANTS COMPRISING THESE COMPOUNDS THE PROCTER & GAMBLE COMPANY (US) 2007-03-08 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070067922-A1 4-Aminophenol derivatives and colorants comprising these compounds KRT18, S100A4, CKAP4 CNR2 4833/4885CNR1 4821/4885PCNA 666/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.